TMPV Swing: A Support Bounce on Margin, +₹5,100
Everything in this journal until now has been options — condors, strangles, 0DTE tents, breakout short puts. This is the first stock swing trade: delivery-based, holding actual shares for days, betting on direction rather than decay.
Result: +₹5,100. A different instrument, a different holding period, and a different set of risks worth being explicit about.
The trade
| Instrument | TMPV (delivery / cash) |
| Bought | 307 shares @ 303.40 on 22-07-2026 |
| Sold | 04-08-2026 |
| Exit price | ~320.01 |
| Move | +16.61 points, ≈ 5.5% |
| Profit | ₹5,100 |
| Capital | ~₹93,144 notional |
| Funding | MTF (Margin Trading Facility) |
The thesis was straightforward technical analysis: 303.40 was a support zone — a level the stock had held before, where buyers had previously stepped in. The bet is that support holds again, the stock bounces, and I capture the move up off the level. It did, over about two weeks, and I exited into the bounce for a 5.5% gain.
Why I exited at 5.5%
The target was deliberately modest, and the reason is MTF.
MTF is margin trading — the broker funds part of the position and charges interest on the borrowed portion for every day I hold it. That changes the arithmetic of a swing trade in two ways. First, the leverage means a 5.5% move on the stock is a larger percentage return on my actual deployed capital than 5.5% suggests. Second, and pulling the other way, the daily interest is a clock running against me — the longer I hold, the more the funding cost eats the gain.
So on an MTF swing, a smaller, faster target is often the right target. A 5% move captured in two weeks, on leverage, with the funding cost still small, is a better trade than holding out for 10% over two months while interest accrues the whole time. I took the 5.5% because on borrowed money, banking a clean bounce beats waiting for a bigger move that the funding cost is quietly taxing. That is a rule I want to keep: on MTF, the holding period is a cost, so the target scales down.
How this fits — and does not fit — the rest of the book
This trade is worth putting next to the options book precisely because it is so different, and because "different instrument" does not automatically mean "diversified."
What is genuinely different:
- Directional, not volatility. The options strategies mostly profit from decay or range. This profits purely from the stock going up. It has no theta working for it and no volatility view — it is a clean long bet on price.
- Defined, capped downside by nature. A long stock position can only go to zero; there is no 2× tail like the naked 0DTE structures, no both-sides whipsaw like the strangle. The risk is bounded and obvious.
- Longer horizon. Two weeks versus the intraday-to-weekly clock of everything else.
What is not as different as it looks:
- It is leveraged. MTF means I am borrowing to hold. Leverage cuts both ways — a support level that fails instead of holding turns a modest drawdown into a larger one on deployed capital, and the interest keeps running while I decide what to do. "Capped downside" is true in principle but leverage sharpens it.
- It is still long the market. TMPV does not move in a vacuum. On a broad-market selloff — the kind that hit my options book on 08-07 — a support level is far more likely to break. A long stock swing on margin is one more position that loses when the market falls, stacked on top of the short puts and strangles that also lose when the market falls. It feels like diversification because it is a different instrument. It is not, on a bad day.
That last point is the same aggregate-exposure theme that runs through this entire journal. Adding a leveraged long stock position to a book that is already implicitly long the market through short puts does not spread my risk. It concentrates it further, in a new wrapper.
The honest attribution
The ₹5,100 came from a support level holding and a two-week bounce arriving before the funding cost mattered. That is a real, repeatable idea — support-zone entries with a modest MTF-appropriate target — and I am happy to have it in the toolkit.
But I want to be clear about what I did not do: I did not have a written stop for what happens if 303.40 breaks instead of holds. On a leveraged position, "support failed" is exactly when a stop matters most, because the interest clock and the leverage compound a losing thesis. This trade won, so the missing stop cost nothing. The pattern of "won, so the missing stop cost nothing" has appeared in this journal enough times that I no longer trust it.
What I am watching
- A written invalidation level on every MTF swing. Support-zone entries have a natural stop: the level itself. If 303.40 is the reason I am in, a decisive close below it is the reason I get out — placed as an order, not held as an intention. This trade did not have one and got away with it.
- Funding cost as an explicit line item. On MTF the interest is a real, daily drag. I want the P&L on these to net the funding cost, so "5.5%" is the number after the cost of the leverage, not before.
- Total long-market exposure across everything. A leveraged long stock, plus short puts, plus strangles, are not three independent bets on a red day. Same refrain, new instrument. The book needs one exposure view, and adding stocks makes that more urgent, not less.
First stock swing, a clean 5.5% off a support bounce, sized and timed for the fact that it was on borrowed money. A good trade — and a leveraged long position I should count as market exposure, not as diversification.
Disclaimer
This is a personal trading journal. It is a record of my own trades, my own money and my own mistakes — nothing more.
Nothing here is a trade recommendation, a tip, a call, or advice of any kind. I am not a registered adviser and I am not qualified to tell anyone what to do with their capital. The stock names, prices, entries and exits above are what I did, not what you should do. Margin trading amplifies both gains and losses and carries funding costs and additional risks.
If you read this blog and place a trade because of it, that trade is yours. I accept no responsibility for anyone else's losses. Do your own research, size for your own risk, and understand that leverage can lose you more, faster, than you expect.